Medsource Ozone BIO Medicals Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Medsource Ozone BIO Medicals Private Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $216.1K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Medsource Ozone BIO Medicals Private Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $216.1K Trade | TransData Nexus

Medsource Ozone BIO Medicals Private Limited

Indian Pharmaceutical Exporter · Medical Devices & Diagnostics Specialist · $216.1K Total Trade · DGFT Verified

Medsource Ozone BIO Medicals Private Limited is an Indian pharmaceutical exporter with a total trade value of $216.1K across 2 products in 1 therapeutic categories. Based on 231 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Diagnostic ($144.0K), Reagent ($72.1K), .

Medsource Ozone BIO Medicals Private Limited — Export Portfolio & Destination Treemap

Medsource Ozone BIO Medicals Private Limited pharmaceutical export portfolio — 2 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Medsource Ozone BIO Medicals Private Limited? — Company Overview & Market Position

Medsource Ozone Biomedicals Private Limited, established in 2003, is a privately held Indian company specializing in the development, production, and marketing of in vitro diagnostic (IVD) products. The company is headquartered in Faridabad, Haryana, India, with its registered office located at 238 LGF, Sant Nagar, East of Kailash, New Delhi, Delhi 110065, India. Medsource Ozone Biomedicals is classified as a private non-government company under the Corporate Identification Number (CIN) U24239DL2003PTC120213. As of the latest available financial data, the company has an authorized capital of ₹1.90 crore and a paid-up capital of ₹1.82 crore. The company employs over 350 individuals across various functions, including research and development, production, sales, service, administration, and support. Medsource Ozone Biomedicals operates a professionally managed structure, with its manufacturing and R&D activities based in Faridabad, near New Delhi.

What Does Medsource Ozone BIO Medicals Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Diagnostic$144.0K 2

Product Portfolio — Top 2 by Export Value

Medsource Ozone BIO Medicals Private Limited exports 2 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Diagnostic	Medical Devices & Diagnostics	$144.0K	146	0.8%	13
2	Reagent	Medical Devices & Diagnostics	$72.1K	85	0.5%	11

Medsource Ozone BIO Medicals Private Limited exports 2 pharmaceutical products across 1 therapeutic categories with a total export value of $216.1K. The top category is Medical Devices & Diagnostics (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Medsource Ozone BIO Medicals Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Medsource Ozone Biomedicals operates manufacturing and research facilities in Faridabad, Haryana, India. The company's manufacturing unit is ISO 13485 compliant, ensuring adherence to international quality management standards for medical devices. This facility serves as the hub for the company's research and development activities, focusing on new product development, product improvement, contract research, process improvement, and cost optimization. The manufacturing plant's capacity and specific specializations are not publicly disclosed.

3Key Leadership

Medsource Ozone Biomedicals is led by a team of directors, including Shailesh Kumar Mittal and Prateek Kumar Mittal. The company's leadership is committed to maintaining high ethical standards, emphasizing honesty, integrity, hard work, loyalty, and transparency. Specific roles and responsibilities of each director are not publicly detailed.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Medsource Ozone BIO Medicals Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Medsource Ozone Biomedicals primarily focuses on the Indian market, with its products being sold across India and neighboring countries through a professional sales team and qualified distribution partners. The company's export activities are limited, with a total export value of $216,000 USD across 231 shipments, indicating minimal presence in regulated markets such as the US, EU, UK, Australia, and Japan. The company's portfolio is concentrated in the Medical Devices & Diagnostics category, with diagnostic products accounting for $144,000 USD and reagents for $72,000 USD. Given the limited export activities, the company has not reported any regulatory filings, approvals, or market access statuses in these regions.

2Emerging Markets

Medsource Ozone Biomedicals has a limited presence in emerging markets, with its export activities primarily focused on neighboring countries. The company's export value of $216,000 USD across 231 shipments suggests minimal penetration in regions such as Africa, Latin America, and Southeast Asia. The company has not reported any WHO prequalification or other certifications that would enable broader access to these markets.

3Geographic Strategy

Medsource Ozone BIO Medicals Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Medsource Ozone Biomedicals has not reported any FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, or inspection histories. The company's limited export activities, totaling $216,000 USD across 231 shipments, suggest minimal engagement with the U.S. market. Consequently, there is no available information regarding the company's compliance with FDA regulations or its standing in the U.S. pharmaceutical market.

2WHO & EU GMP

Medsource Ozone Biomedicals has not reported obtaining WHO prequalification, EU Good Manufacturing Practice (GMP) certificates, or European Directorate for the Quality of Medicines & HealthCare (EDQM) status. The company's export activities are limited, with a total export value of $216,000 USD across 231 shipments, indicating minimal engagement with international markets that require such certifications. As a result, there is no available information regarding the company's compliance with WHO or EU GMP standards.

3CDSCO & Indian Regulatory

Medsource Ozone BIO Medicals Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Medsource Ozone Biomedicals operates in the in vitro diagnostics (IVD) sector, competing with other manufacturers of clinical diagnostic products. While specific market share data is not publicly available, the company's export value of $216,000 USD across 231 shipments indicates a modest presence in the global market. The company's focus on diagnostic products and reagents suggests competition with other specialized IVD manufacturers. However, the limited export activities and market share indicate that Medsource Ozone Biomedicals is a smaller player in the global IVD market.

2Key Differentiators

Medsource Ozone Biomedicals' key differentiators include its in-house research and development capabilities, which enable the company to develop, produce, and continuously improve its product offerings. The company's manufacturing facility in Faridabad is ISO 13485 compliant, ensuring adherence to international quality management standards for medical devices. Additionally, the company emphasizes ethical values such as honesty, integrity, hard work, loyalty, and transparency, which contribute to its reputation in the industry.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Medsource Ozone BIO Medicals Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Medsource Ozone Biomedicals has a track record of developing, producing, and continuously improving its in vitro diagnostic products. The company's manufacturing facility in Faridabad is ISO 13485 compliant, indicating adherence to international quality management standards for medical devices. The company employs over 350 individuals across various functions, including research and development, production, sales, service, administration, and support, reflecting a robust operational structure. However, the company's limited export activities, totaling $216,000 USD across 231 shipments, suggest a modest presence in the global market. This limited export volume may impact the consistency and reliability of supply for international customers.

2Certifications to Verify

Importers should verify the following certifications when considering Medsource Ozone Biomedicals as a supplier:

ISO 13485 Certification: This certification indicates that the company's manufacturing facility adheres to international quality management standards for medical devices.

Frequently Asked Questions — Medsource Ozone BIO Medicals Private Limited

How many pharmaceutical products does Medsource Ozone BIO Medicals Private Limited export from India?

Medsource Ozone BIO Medicals Private Limited exports 2 pharmaceutical products across 1 therapeutic categories. The top exports are Diagnostic ($144.0K), Reagent ($72.1K). Total export value is $216.1K.

What is Medsource Ozone BIO Medicals Private Limited's total pharmaceutical export value?

Medsource Ozone BIO Medicals Private Limited's total pharmaceutical export value is $216.1K, based on 231 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Medsource Ozone BIO Medicals Private Limited cover?

Medsource Ozone BIO Medicals Private Limited exports across 1 therapeutic categories. The largest are Medical Devices & Diagnostics (100.0%, 2 products).

Get Full Medsource Ozone BIO Medicals Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.